PTGS2 and neoplasm: This study focuses on developing strategies to overcome these challenges, specifically targeting cyclooxygenase-2 (COX-2) and tumor-associated macrophages (TAMs), which hold promise for restoring immune cell function and enhancing the effectiveness of immunotherapy.